Recent Updates
Recently added Catalysts
BMY Positive Sentiment

Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference

Tuesday, February 24, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bristol Myers Squibb announced its participation in the TD Cowen 46th Annual Health Care Conference, scheduled for March 2, 2026. The company will engage in a fireside chat at 9:50 a.m. ET, which will be accessible to investors and the public via their investor website. An archived version of the session will be available afterward.
Price reaction · baseline $61.25 (2026-02-23 close) · hit pre-market · 1 other BMY headline(s) in the window, move may be shared
day 0 close · peak
+0.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Bristol Myers Squibb is actively engaging with investors.
  • Participation in a notable health care conference highlights company visibility.
  • The company is committed to innovation in medicine.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
Muraglitazar
Phase 3 · Type 2 Diabetes

Full Press Release Details

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the TD Cowen 46thAnnual Health Care Conference on Monday, March 2, 2026.
The company will take part in a fireside chat beginning at 9:50 a.m. ET.
Investors and the general public are invited to listen to the session by visitinghttp://investor.bms.com. An archived edition of the session will be available following its conclusion.
About Bristol Myers Squibb: Transforming Patients’ Lives Through ScienceAt Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us atBMS.comand follow us onLinkedIn,X,YouTube,FacebookandInstagram.
corporatefinancial-news

Frequently Asked Questions

When will Bristol Myers Squibb participate in the conference?

Bristol Myers Squibb will participate in the TD Cowen conference on March 2, 2026.

What time is the fireside chat scheduled?

The fireside chat is scheduled to begin at 9:50 a.m. ET.

How can the public access the conference session?

The public can listen to the session by visiting Bristol Myers Squibb's investor website.

Will there be a recording of the session available?

Yes, an archived edition of the session will be available after its conclusion.

ShareAdd on Google
Tags: BMY Viatris Investor Conferences Healthcare TD Cowen health care conference investor relations Bristol Myers Squibb
Last updated: Feb 24, 2026

Biotech snapshot

Cash runway
$11464M liquidity · $0M/mo burn
Low dilution risk
Lead asset
MuraglitazarPhase 3
Type 2 Diabetes →

Catalyst track record

+20%
best trade around BMY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for BMY.

See every catalyst's timing & PoA →